Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line.
about
P1343
Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infectionEpstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions.Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein-Barr virus-associated T cell and natural killer cell lymphomaDeciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferationsThe heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas.Hypersensitivity to mosquito bites associated with natural killer cell-derived large granular lymphocyte lymphocytosis: a case report in KoreaGene expression analysis of hypersensitivity to mosquito bite, chronic active EBV infection and NK/T-lymphoma/leukemia.Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cellsc-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma.Role of latent membrane protein 1 in chronic active Epstein-Barr virus infection-derived T/NK-cell proliferation.Expression of CD70 in nasal natural killer/T cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble CD27.Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells.Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection.Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma.Presence of natural killer-cell clones with variable proliferative capacity in chronic active Epstein-Barr virus infection.Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.A case of hypersensitivity to mosquito bite associated with Epstein-barr viral infection and natural killer cell lymphocytosis.Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection.Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15.Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.Epstein-Barr virus-specific T-cell cytotoxicity is mediated through the perforin pathway in patients with lymphoproliferative disorders after allogeneic bone marrow transplantation.A distinct subtype of Epstein Barr virus positive T/NK-cell lymphoproliferative disorder: Adult patients with chronic active Epstein Barr virus infection-like features.An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection.Antitumor effects of duvelisib on Epstein-Barr virus-associated lymphoma cells.Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.Screening for 15 pathogenic viruses in human cell lines registered at the JCRB Cell Bank: characterization of in vitro human cells by viral infection.
P2860
Q24684237-1D296EFC-777E-4023-8904-499338E29BE9Q34576340-5E3C80AD-F671-4BD8-99F3-05EB950F7CCFQ35051804-49EFCABB-F2AB-4469-836B-95A031921A00Q35232848-F64F1883-46CA-4768-9B8B-CB641DFD091CQ35336213-7AE06670-953C-42DB-AE08-25E010319E3FQ35937078-0141ACE9-28D9-4F63-91B7-29539843437AQ38435146-630EED2D-E1AD-4892-A63E-FAE4405C3C63Q38741546-6ED17EAA-9DFC-46DB-AA6E-5D8F1E542519Q38878238-A51D986D-6E49-46AD-975A-97C3932D8B37Q38998165-79941622-FC62-43A5-8F2E-03C33FCEE457Q39233648-9E9E0D5E-8422-4029-ADD1-C0F7720F3709Q39454860-42BDE10B-10B5-4EF0-8A00-07169509C433Q39618066-6A8C52D5-F3E7-415F-BB61-64A863330D26Q40552301-992E4739-858B-42AA-9850-19A5070A9040Q40746520-9F9D70C4-CA31-43D4-A85E-FDB67158C03DQ40804641-48447E4C-09C9-4841-8D8B-CFDED334E352Q42117115-12C6431F-8524-4AD8-B9A8-21259157DA8FQ42262493-DF95CF5A-FC27-412C-AABE-2918AF701B9CQ43920073-9D288087-78BF-4065-99F2-504B64AAF403Q45723253-EB1A3803-23F4-444A-9079-E97DA7C57A2DQ45733739-825A322E-C347-43C5-AC52-B4F3E42BCBE8Q47565503-54F733A4-5237-4303-8257-D4382634D723Q52586519-EC57BAE1-637E-40D4-9CBD-D50E47665BB4Q52664561-82D640F6-3FF1-4BDB-9C83-5105FD88D168Q52718168-40D45A24-C2E6-4D22-AAF8-03C6BF0AB673Q54981043-56A1EE81-5803-4B4F-8ADF-459191BBB5B3
P2860
Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Characterization of Epstein-Ba ...... 2-dependent NK-like cell line.
@ast
Characterization of Epstein-Ba ...... 2-dependent NK-like cell line.
@en
type
label
Characterization of Epstein-Ba ...... 2-dependent NK-like cell line.
@ast
Characterization of Epstein-Ba ...... 2-dependent NK-like cell line.
@en
prefLabel
Characterization of Epstein-Ba ...... 2-dependent NK-like cell line.
@ast
Characterization of Epstein-Ba ...... 2-dependent NK-like cell line.
@en
P2093
P2860
P1476
Characterization of Epstein-Ba ...... 2-dependent NK-like cell line.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2249.1999.00836.X
P4510
P577
1999-03-01T00:00:00Z